New Study Finds FDA’s Inspection Pause May Have Compromised Drug Quality While Agency Says It's Ramping Back Up
insider.thefdagroup.com
The FDA's pausing its onsite inspections may have had negative consequences for drug quality, according to an analysis in Health Affairs. The agency said more inspections are coming.
New Study Finds FDA’s Inspection Pause May Have Compromised Drug Quality While Agency Says It's Ramping Back Up
New Study Finds FDA’s Inspection Pause May…
New Study Finds FDA’s Inspection Pause May Have Compromised Drug Quality While Agency Says It's Ramping Back Up
The FDA's pausing its onsite inspections may have had negative consequences for drug quality, according to an analysis in Health Affairs. The agency said more inspections are coming.